DOCSLIB.ORG

Development of a Functional Assay for CHD7, a Protein Involved in CHARGE Syndrome Gara Samara Brajadenta

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Development of a Functional Assay for CHD7, a Protein Involved in CHARGE Syndrome Gara Samara Brajadenta Development of a functional assay for CHD7, a protein involved in CHARGE syndrome Gara Samara Brajadenta To cite this version: Gara Samara Brajadenta. Development of a functional assay for CHD7, a protein involved in CHARGE syndrome. Human genetics. Université de Poitiers, 2019. English. NNT : 2019POIT1401. tel-02459642 HAL Id: tel-02459642 https://tel.archives-ouvertes.fr/tel-02459642 Submitted on 29 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THESE Pour l’obtention du Grade de DOCTEUR DE L’UNIVERSITÉ DE POITIERS (Faculté Médecine et Pharmacie) (Diplôme National – Arrêté du 25 mai 2016) École Doctorale : Sciences Biologiques et Santé Secteur de Recherche : Aspects Moléculaires et Cellulaires de la Biologie Présenté par : Gara Samara Brajadenta ****************************** Mise au Point d’un Test Fonctionnel pour la Protéine CHD7 Impliquée dans le Syndrome CHARGE (Development of a Functional Assay for CHD7, a Protein Involved in CHARGE Syndrome) ****************************** Directeur de Thèse : Professeur Alain Kitzis Co-directeur de Thèse : Docteur Vincent Thoreau ****************************** Soutenue le 14 juin 2019 devant la Commission d’Examen ***************************** JURY Professeur Thierry Bergès Université de Poitiers Président Professeur Patrick Vourc’h Université de Tours Rapporteur Docteur Veronique Pingault Université Paris Descartes Rapporteur Professeur Sultana MH Faradz Université Diponegoro Examinateur Professeur Alain Kitzis Université de Poitiers Directeur de thèse Docteur Vincent Thoreau Université de Poitiers Co-Directeur de thèse Preface This thesis is written as partial fulfillment of the requirements to obtain a Ph.D. degree at the Faculty of Medicine and Pharmacy, the University of Poitiers, France. The work was carried out from October 2015 to June 2019 in the laboratory EA-3808 Neurovascular Unit and Cognitive Impairments, University of Poitiers, France under the supervision of Professor Alain Kitzis and Doctor Vincent Thoreau. The work was funded by University of Poitiers and was also supported by Indonesia Endowment Fund for Education (LPDP), Ministry of Finance of the Republic of Indonesia. Gara Samara Brajadenta Poitiers, June 2019 ACKNOWLEDGMENTS Many people have contributed their skills into this research; this work would have been impossible without their help and assistance. I would like to express my sincere gratitude to my supervisor, Prof. Alain Kitzis, MD, PhD, for his guidance, time to teach me and endless encouragement. I am also thankful to my co-supervisor Dr. Vincent Thoreau, for his guidance, knowledge sharing, teaching me basic techniques of the molecular biology, his close supervision in almost all my days in the laboratory, for editing my thesis and for widening my research from various perspectives. I would like to thank all staff of laboratory of genetics and EA-3808 Neurovascular Unit and Cognitive Impairments, Faculty of Medicine and Pharmacy, the University of Poitiers for their cooperation and friendship they have shared over the years. Particularly, I would like to thank Dr. Frédéric Bilan, Dr. Sylvie Patri, and Dr. Montserrat Rodriguez-Ballesteros for their scientific support during my research, especially for teaching me how to interpret the molecular analysis. My sincere gratitude goes to Prof. Patrick Vourc’h from the University of Tours and Dr. Veronique Pingault from the University of Paris Descartes for accepting to evaluate my PhD report. I would like to thank Prof. Sultana MH Faradz, MD, PhD from the Diponegoro University, Semarang, Indonesia and Prof. Thierry Bergès from the University of Poitiers, for honoring me by their presence in the jury of my thesis. My grateful thank also goes to Prof. Guylène Page, who provided me an opportunity to join EA-3808 team, and who gave me access to the laboratory and research facilities. Extraordinary gratitude goes to all down at Indonesian Endowment Fund for Education (LPDP) Ministry of Finance, the Republic of Indonesia for helping and providing the funding for the study and the research. I would like to express my special thanks to Prof. Gérard Mauco, MD, PhD and Prof. Sultana MH Faradz, MD, PhD, who have given me recommendations to continue my PhD at the University of Poitiers. Last but not the least, I would like to thank Dr. Affandi (former dean), Dr. Catur Setiya Sulistiyana, the dean of Faculty of Medicine, and Dr. Mukarto Siswoyo, the rector of Swadaya Gunung Jati University, Cirebon, Indonesia for giving me the golden opportunity to do this excellent PhD thesis in France. TABLE OF CONTENTS Abstract …............................................................................................. i Résumé ……………………………………………………………………... ii List of Abbreviations …………............................................................... iii List of Figures ………………………………………………………………. v List of Tables …………………………………….…………………………. viii List of Publication ................................................................................. ix Synopsis ............................................................................................... x CHAPTER I. INTRODUCTION 1.1 General Introduction ……...……………………………………………. 2 1.2 Background ……………………...……………………………………… 2 1.2.1 Molecular Diagnosis of CHARGE Syndrome ..…………..….….. 2 1.2.2 Challenges in the Development of Functional Assay of CHD7 .. 4 1.3 Objectives ………………………. ……………………………………… 5 CHAPTER II. LITERATUR REVIEW 2.1 Overview of CHARGE Syndrome ……………........…………………. 8 2.1.1 CHARGE: From Association to Syndrome ..…………..….…….. 8 2.1.2 Prevalence and Demographics ........................…………………. 10 2.1.3 Inheritance Pattern ....................................……………………… 10 2.1.4 Variability in CHARGE Clinical Features .……………………….. 11 2.1.5 Clinical Criteria Diagnosis of CHARGE Syndrome .................... 18 2.2 Cloning of CHD7 Gene and Mutations in the CHD7 Gene ………... 20 2.3 Updated Diagnosis Criteria for CHARGE Syndrome ...................… 23 2.4 Genetic Causes of CHARGE Syndrome ...............…………………. 25 2.5 CHD7 Protein and Its Function .............................…………………. 27 2.6 Pathomechanism of CHARGE Syndrome ...................................... 33 2.7 Novel Classification System to Predict the Pathogenicity of CHD7 Missense Variants and Prospective .............................................. 36 CHAPTER III. MATERIALS, PATIENTS, AND METHODS 3.1 Molecular Diagnosis of CHARGE Syndrome .............………….…. 41 3.1.1 Chromosome Analysis ............................................................. 41 3.1.2 DNA Extraction ............................................………….………… 42 3.1.3 Targeted NGS Gene Panel ............................…......…………… 43 3.1.4 Mutation Confirmation by Sequencing Analysis ......…………… 44 3.2 Development of a Functional Assay of CHD7 Variants …............... 45 3.2.1 Patients and Bioinformatic Prediction Tools ............................ 45 3.2.2 Plasmids .....................................................……......…………… 49 3.2.3 Site-Directed Mutagenesis ......................................…………… 49 3.2.4 Confirmation of Mutated Variants by Sequencing Analysis ...… 52 3.2.5 Cell Culture and Transfection ..................................…………… 53 3.2.6 Cell Lysis and Protein Assay ...................................…………… 54 3.2.7 Western blot Analysis ............................................................... 55 3.2.8 Immunofluorescence .................................……......…………… 56 3.2.9 Antibodies .................................……......……………................. 57 3.2.10 RNA Extraction and cDNA Synthesis ..................................… 58 3.2.11 Quantitative RT-PCR .............................................................. 59 3.2.11.1 General Protocol ................................................................ 59 3.2.11.2 Choice of Reporter Genes ................................................. 61 3.2.12 Sensitivity and Specificity Test ............................................… 64 3.3 Genome Modification Technologies ...........................………….…. 65 3.3.1 CRISPR/Cas9 System ............................................................. 66 3.3.2 Stages and Types of the CRISPR/Cas .................................... 67 3.3.3 Application of CRISPR/Cas9 System for Genome Modification in Functional Study .................................................................. 70 3.3.4 DNA Reparation System .......................................................... 72 3.4 Functional Assay of Endogenously Expressed CHD7 Missense Variants using CRISPR/Cas9 System ......................................... 76 3.4.1 Choice of CHD7 Gene Sequence to Target with the CRISPR/Cas9 ......................................................................... 76 3.4.2 Cas9 Nuclease and Single Guide RNA (sgRNA) Constructs ... 76 3.4.3 Repair-Template Design: Single-Stranded DNA Oligonucleotides ssODNs and Double-Stranded Targeting Plasmids ................................................................................. 79 3.4.4 Transfection
Load more

Recommended publications
  • 16.1 | Regulation of Gene Expression
    436 Chapter 16 | Gene Expression 16.1 | Regulation of Gene Expression By the end of this section, you will be able to do the following: • Discuss why every cell does not express all of its genes all of the time • Describe how prokaryotic gene regulation occurs at the transcriptional level • Discuss how eukaryotic gene regulation occurs at the epigenetic, transcriptional, post-transcriptional, translational, and post-translational levels For a cell to function properly, necessary proteins must be synthesized at the proper time and place. All cells control or regulate the synthesis of proteins from information encoded in their DNA. The process of turning on a gene to produce RNA and protein is called gene expression. Whether in a simple unicellular organism or a complex multi-cellular organism, each cell controls when and how its genes are expressed. For this to occur, there must be internal chemical mechanisms that control when a gene is expressed to make RNA and protein, how much of the protein is made, and when it is time to stop making that protein because it is no longer needed. The regulation of gene expression conserves energy and space. It would require a significant amount of energy for an organism to express every gene at all times, so it is more energy efficient to turn on the genes only when they are required. In addition, only expressing a subset of genes in each cell saves space because DNA must be unwound from its tightly coiled structure to transcribe and translate the DNA. Cells would have to be enormous if every protein were expressed in every cell all the time.
    [Show full text]
  • Formation of Heterodimers Between Wild Type and Mutant Trp Aporepressor Polypeptides of Eschem'chia Coli Thomas J
    PROTEINS: Structure, Function, and Genetics 4:173-181 (1988) Formation of Heterodimers Between Wild Type and Mutant trp Aporepressor Polypeptides of Eschem'chia coli Thomas J. Graddis,' Lisa S. Klig,' Charles Yanofsky,' and Dale L. Oxender' 'Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109 and 'Department of Biological Sciences, Stanford University, Stanford, California 94305 ABSTRACT Availability of the three-dimen- tophan.1-6 The trp aporepressor is activated by the sional structure of the trp repressor of Escherichia binding of two molecules of its corepressor. Once ac- coli and a large group of repressor mutants has per- tivated, trp repressor binds to the operators of the trp, mitted the identification and analysis of mutants aroH, and trpR operons, regulating transcription ini- with substitutions of the amino acid residues that tiati~n.~,'The aroH and trp operons encode biosyn- form the tryptophan binding pocket. Mutant apore- thetic enzymes, whereas the trpR operon encodes the pressors selected for study were overproduced using trp aporepressor. The trpR gene has been cloned and a multicopy expression plasmid. Equilibrium di- its nucleotide sequence determined.3 The aporepres- alysis with ''C-tryptophan and purified mutant and sor and repressor have been purified and the crystal wild type aporepressors was employed to determine structures of both have been solved at high resolu- tryptophan binding constants. The results obtained ti~n.~-"The trp aporepressor is a dimer of identical indicate that replacement of threonine 44 by methi- 107 residue polypeptides." The existence of the three- onine (TM44) or arginine 84 by histidine (RH84) low- dimensional structures, and the availability of many ers the affinity for tryptophan approximately two- repressor mutants,2i12has facilitated this analysis of and four-fold, respectively.
    [Show full text]
  • Transcriptome-Wide Profiling of Cerebral Cavernous Malformations
    www.nature.com/scientificreports OPEN Transcriptome-wide Profling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signatures Santhilal Subhash 2,8, Norman Kalmbach3, Florian Wegner4, Susanne Petri4, Torsten Glomb5, Oliver Dittrich-Breiholz5, Caiquan Huang1, Kiran Kumar Bali6, Wolfram S. Kunz7, Amir Samii1, Helmut Bertalanfy1, Chandrasekhar Kanduri2* & Souvik Kar1,8* Cerebral cavernous malformations (CCMs) are low-fow vascular malformations in the brain associated with recurrent hemorrhage and seizures. The current treatment of CCMs relies solely on surgical intervention. Henceforth, alternative non-invasive therapies are urgently needed to help prevent subsequent hemorrhagic episodes. Long non-coding RNAs (lncRNAs) belong to the class of non-coding RNAs and are known to regulate gene transcription and involved in chromatin remodeling via various mechanism. Despite accumulating evidence demonstrating the role of lncRNAs in cerebrovascular disorders, their identifcation in CCMs pathology remains unknown. The objective of the current study was to identify lncRNAs associated with CCMs pathogenesis using patient cohorts having 10 CCM patients and 4 controls from brain. Executing next generation sequencing, we performed whole transcriptome sequencing (RNA-seq) analysis and identifed 1,967 lncRNAs and 4,928 protein coding genes (PCGs) to be diferentially expressed in CCMs patients. Among these, we selected top 6 diferentially expressed lncRNAs each having signifcant correlative expression with more than 100 diferentially expressed PCGs. The diferential expression status of the top lncRNAs, SMIM25 and LBX2-AS1 in CCMs was further confrmed by qRT-PCR analysis. Additionally, gene set enrichment analysis of correlated PCGs revealed critical pathways related to vascular signaling and important biological processes relevant to CCMs pathophysiology.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Molecular Diagnostic Requisition
    BAYLOR MIRACA GENETICS LABORATORIES SHIP TO: Baylor Miraca Genetics Laboratories 2450 Holcombe, Grand Blvd. -Receiving Dock PHONE: 800-411-GENE | FAX: 713-798-2787 | www.bmgl.com Houston, TX 77021-2024 Phone: 713-798-6555 MOLECULAR DIAGNOSTIC REQUISITION PATIENT INFORMATION SAMPLE INFORMATION NAME: DATE OF COLLECTION: / / LAST NAME FIRST NAME MI MM DD YY HOSPITAL#: ACCESSION#: DATE OF BIRTH: / / GENDER (Please select one): FEMALE MALE MM DD YY SAMPLE TYPE (Please select one): ETHNIC BACKGROUND (Select all that apply): UNKNOWN BLOOD AFRICAN AMERICAN CORD BLOOD ASIAN SKELETAL MUSCLE ASHKENAZIC JEWISH MUSCLE EUROPEAN CAUCASIAN -OR- DNA (Specify Source): HISPANIC NATIVE AMERICAN INDIAN PLACE PATIENT STICKER HERE OTHER JEWISH OTHER (Specify): OTHER (Please specify): REPORTING INFORMATION ADDITIONAL PROFESSIONAL REPORT RECIPIENTS PHYSICIAN: NAME: INSTITUTION: PHONE: FAX: PHONE: FAX: NAME: EMAIL (INTERNATIONAL CLIENT REQUIREMENT): PHONE: FAX: INDICATION FOR STUDY SYMPTOMATIC (Summarize below.): *FAMILIAL MUTATION/VARIANT ANALYSIS: COMPLETE ALL FIELDS BELOW AND ATTACH THE PROBAND'S REPORT. GENE NAME: ASYMPTOMATIC/POSITIVE FAMILY HISTORY: (ATTACH FAMILY HISTORY) MUTATION/UNCLASSIFIED VARIANT: RELATIONSHIP TO PROBAND: THIS INDIVIDUAL IS CURRENTLY: SYMPTOMATIC ASYMPTOMATIC *If family mutation is known, complete the FAMILIAL MUTATION/ VARIANT ANALYSIS section. NAME OF PROBAND: ASYMPTOMATIC/POPULATION SCREENING RELATIONSHIP TO PROBAND: OTHER (Specify clinical findings below): BMGL LAB#: A COPY OF ORIGINAL RESULTS ATTACHED IF PROBAND TESTING WAS PERFORMED AT ANOTHER LAB, CALL TO DISCUSS PRIOR TO SENDING SAMPLE. A POSITIVE CONTROL MAY BE REQUIRED IN SOME CASES. REQUIRED: NEW YORK STATE PHYSICIAN SIGNATURE OF CONSENT I certify that the patient specified above and/or their legal guardian has been informed of the benefits, risks, and limitations of the laboratory test(s) requested.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Beyond Traditional Morphological Characterization of Lung
    Cancers 2020 S1 of S15 Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups Giovanni Centonze, Davide Biganzoli, Natalie Prinzi, Sara Pusceddu, Alessandro Mangogna, Elena Tamborini, Federica Perrone, Adele Busico, Vincenzo Lagano, Laura Cattaneo, Gabriella Sozzi, Luca Roz, Elia Biganzoli and Massimo Milione Table S1. Genes Frequently mutated in Typical Carcinoids (TCs). Mutation Original Entrez Gene Gene Rate % eukaryotic translation initiation factor 1A X-linked [Source: HGNC 4.84 EIF1AX 1964 EIF1AX Symbol; Acc: HGNC: 3250] AT-rich interaction domain 1A [Source: HGNC Symbol;Acc: HGNC: 4.71 ARID1A 8289 ARID1A 11110] LDL receptor related protein 1B [Source: HGNC Symbol; Acc: 4.35 LRP1B 53353 LRP1B HGNC: 6693] 3.53 NF1 4763 NF1 neurofibromin 1 [Source: HGNC Symbol;Acc: HGNC: 7765] DS cell adhesion molecule like 1 [Source: HGNC Symbol; Acc: 2.90 DSCAML1 57453 DSCAML1 HGNC: 14656] 2.90 DST 667 DST dystonin [Source: HGNC Symbol;Acc: HGNC: 1090] FA complementation group D2 [Source: HGNC Symbol; Acc: 2.90 FANCD2 2177 FANCD2 HGNC: 3585] piccolo presynaptic cytomatrix protein [Source: HGNC Symbol; Acc: 2.90 PCLO 27445 PCLO HGNC: 13406] erb-b2 receptor tyrosine kinase 2 [Source: HGNC Symbol; Acc: 2.44 ERBB2 2064 ERBB2 HGNC: 3430] BRCA1 associated protein 1 [Source: HGNC Symbol; Acc: HGNC: 2.35 BAP1 8314 BAP1 950] capicua transcriptional repressor [Source: HGNC Symbol; Acc: 2.35 CIC 23152 CIC HGNC:
    [Show full text]
  • Application of Models for Biomolecular Structure and Interactions to Understand and Influence Biological Function
    Application of Models for Biomolecular Structure and Interactions to Understand and Influence Biological Function Zur Erlangung des akademischen Grades eines DOKTORS DER NATURWISSENSCHAFTEN (Dr. rer. nat.) Fakultät für Chemie und Biowissenschaften Karlsruher Institut für Technologie (KIT) - Universitätsbereich genehmigte DISSERTATION von Irene Meliciani aus Rom (Italien) Dekan: Prof. Dr. Martin Bastmeyer Referent: Prof. Dr. Stefan Bräse Korreferent: Apl. Prof. Dr. Wolfgang Wenzel Tag der mündlichen Prüfung: 19.10.2011 a mamma e papà Application of Models for Biomolecular Structure and Interactions to Understand and Influence Biological Function Irene Meliciani Karlsruher Institut für Technologie Institut für Nanotechnologie Intitut für Organische Chemie Zusammenfassung Die Forschung in den Lebenswissenschaften hat in den letzten Jahrzehnten zu einem enormen Wissensgewinns bezüglich der Abläufe zellulärer Prozesse und ihrer Steuerung geführt. Die Steuerung biologischer Prozesse wird vielfach über Kontaktwechselwirkungen der daran beteiligten Biomoleküle bewältigt. Mit dieser Arbeit möchte ich zu einem besseren Verständnis biomolekularer Interaktionen beitragen. Ein Teil dieser Arbeit beschäftigt sich mit der Untersuchung von Proteininteraktionen, wobei als Methoden für die Modellierung von Protein-Protein-Wechselwirkungen (POEM) und für die Protein-Liganden-Wechselwirkung (FLEXSCREEN) eingesetzt wurden. Es wurden die Interaktionen der Chemokinrezeptoren CCR3 und CXCR1 mit für den Entzündungsverlauf wichtigen Steuerungsmolekülen (Chemokinen)
    [Show full text]
  • Teaching Gene Regulation in the High School Classroom, AP Biology, Stefanie H
    Wofford College Digital Commons @ Wofford Arthur Vining Davis High Impact Fellows Projects High Impact Curriculum Fellows 4-30-2014 Teaching Gene Regulation in the High School Classroom, AP Biology, Stefanie H. Baker Wofford College, [email protected] Marie Fox Broome High School Leigh Smith Wofford College Follow this and additional works at: http://digitalcommons.wofford.edu/avdproject Part of the Biology Commons, and the Genetics Commons Recommended Citation Baker, Stefanie H.; Fox, Marie; and Smith, Leigh, "Teaching Gene Regulation in the High School Classroom, AP Biology," (2014). Arthur Vining Davis High Impact Fellows Projects. Paper 22. http://digitalcommons.wofford.edu/avdproject/22 This Article is brought to you for free and open access by the High Impact Curriculum Fellows at Digital Commons @ Wofford. It has been accepted for inclusion in Arthur Vining Davis High Impact Fellows Projects by an authorized administrator of Digital Commons @ Wofford. For more information, please contact [email protected]. High Impact Fellows Project Overview Project Title, Course Name, Grade Level Teaching Gene Regulation in the High School Classroom, AP Biology, Grades 9-12 Team Members Student: Leigh Smith High School Teacher: Marie Fox School: Broome High School Wofford Faculty: Dr. Stefanie Baker Department: Biology Brief Description of Project This project sought to enhance high school students’ understanding of gene regulation as taught in an Advanced Placement Biology course. We accomplished this by designing and implementing a lab module that included a pre-lab assessment, a hands-on classroom experiment, and a post-lab assessment in the form of a lab poster. Students developed lab skills while simultaneously learning about course content.
    [Show full text]
  • Mutant Tryptophan Aporepressors with Altered Specificities Of
    Copyright 0 1991 by the Genetics Society of America Mutant Tryptophan Aporepressors With Altered Specificitiesof Corepressor Recognition Dennis N. Arvidson,' Michael Shapiro' and Philip Youderian' Department of Biological Sciences, University of Southern Calqornia, Los Angeles, Calqornia 90089 Manuscript received November 20, 1990 Accepted for publication January 19, 199 1 ABSTRACT The Escherichia coli trpR gene encodes tryptophan aporepressor, which binds the corepressor ligand, L-tryptophan, to form an active repressor complex. The side chain of residue valine 58 of Trp aporepressor sits at the bottom of the corepressor @-tryptophan) binding pocket. Mutant trpR genes encoding changes of Vals8 to the other 19 naturally occurring amino acids were made. Each of the mutant proteins requires a higher intracellular concentration of tryptophan for activation of DNA binding than wild-type aporepressor. Whereas wild-type aporepressor is activated better by 5- methyltryptophan (5-MT) than by tryptophan, IlesHand other mutant aporepressors prefer tryptophan to 5-MT as corepressor, and Ala5' and GIY'~prefer 5-MT much more strongly than wild-type aporepressor in vivo. These mutant aporepressors are the first examples of DNA-binding proteins with altered specificities ofcofactor recognition. ANY regulatory proteins areallosteric, and bind intermonomer interactions stabilize its extraordinary M small metabolic intermediates that modify their hydrophobic core. The aporepressor dimer denatures activities, allowing the intracellular pattern of gene at a very high temperature (>go") (BAEet al. 1988). expression to respond to physiologicalchange. For Comparisons of the crystal structures of repressor example, the Escherichia coli tryptophan aporepressor (SCHEVITZet al. 1985; LAWSONet al. 1988;OTWI- (TrpR) protein binds DNA poorly. However, when NOWSKI et al.
    [Show full text]
  • Development of Novel Transgenic Zebrafish
    DEVELOPMENT OF NOVEL TRANSGENIC ZEBRAFISH MODELS AND THEIR APPLICATION TO STUDIES ON ENVIRONMENTAL OESTROGENS Submitted by Jon Marc Green to the University of Exeter as a thesis for the degree of Doctor of Philosophy in Biological Sciences, September 2016 This thesis is available for Library use on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. I certify that all material in this thesis which is not my own work has been identified and that no material has previously been submitted and approved for the award of a degree by this or any other University. (Signature) ……………………………………………(Jon Marc Green) 1 Abstract Oestrogenic chemicals have become increasingly associated with health effects in wildlife populations and humans. Transgenic animal models have been developed to understand the mechanisms by which these oestrogenic chemicals alter hormonal signalling pathways and how these alterations can lead to chronic health effects. The use of highly informative transgenic animal models will also result in better use and potential reduction of intact animals used in animal testing in line with the principles of the 3Rs. In this thesis work, two novel oestrogen responsive transgenic zebrafish models have been generated to investigate the effects of oestrogenic chemicals, identify their tissue targets and better understand the temporal dynamics of these responses. Both models express the pigment-free ‘Casper’ (a mutant line lacking skin pigment) phenotype, which facilitate identification of responding target tissues in the whole fish in all fish life stages (embryos to adults). The oestrogen response element green fluorescent (ERE-GFP)-Casper model was generated by crossing an established ERE-GFP line with the skin pigment free Casper line.
    [Show full text]